The bone marrow microenvironment is similarly impaired in allogeneic hematopoietic stem cell transplantation patients with early and late poor graft function

Y Kong; Y-T Wang; W Han; Y-J Chang; X-H Zhang; Z-F Jiang; X-J Huang

doi:10.1038/bmt.2015.229

journal article Oct 05, 2015

The bone marrow microenvironment is similarly impaired in allogeneic hematopoietic stem cell transplantation patients with early and late poor graft function

Y Kong Y-T Wang W Han Y-J Chang X-H Zhang Z-F Jiang X-J Huang

Bone Marrow Transplantation Vol. 51 No. 2 pp. 249-255 · Springer Science and Business Media LLC

View at Publisher Save 10.1038/bmt.2015.229

Topics

No keywords indexed for this article. Browse by subject →

References

26

[1]

Larocca A, Piaggio G, Podestà M, Pitto A, Bruno B, Di Grazia C et al. Boost of CD34+-selected peripheral blood cells without further conditioning in patients with poor graft function following allogeneic stem cell transplantation. Haematologica 2006; 91: 935–940.

[2]

Kong Y, Chang YJ, Wang YZ, Chen YH, Han W, Wang Y et al. Association of an impaired bone marrow microenvironment with secondary poor graft function after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2013; 19: 1465–1473. 10.1016/j.bbmt.2013.07.014

[3]

Liu X, Wu M, Peng Y, Chen X, Sun J, Huang F et al. Improvement in poor graft function after allogeneic hematopoietic stem cell transplantation upon administration of mesenchymal stem cells from third-party donors: a pilot prospective study. Cell Transplant 2014; 23: 1087–1098. 10.3727/096368912x661319

[4]

Sun YQ, He GL, Chang YJ, Xu LP, Zhang XH, Han W et al. The incidence, risk factors, and outcomes of primary poor graft function after unmanipulated haploidentical stem cell transplantation. Ann Hematol 2015; 94: 1699–1705. 10.1007/s00277-015-2440-x

[5]

Chang YJ, Zhao XY, Xu LP, Zhang XH, Wang Y, Han W et al. Donor-specific anti-human leukocyte antigen antibodies were associated with primary graft failure after unmanipulated haploidentical blood and marrow transplantation: a prospective study with randomly assigned training and validation sets. J Hematol Oncol 2015; 8: 84. 10.1186/s13045-015-0182-9

[6]

Reisner Y, Hagin D, Martelli MF . Haploidentical hematopoietic transplantation: current status and future perspectives. Blood 2011; 118: 6006–6017. 10.1182/blood-2011-07-338822

[7]

Olsson R, Remberger M, Schaffer M, Berggren DM, Svahn bone marrow, Mattsson J et al. Graft failure in the modern era of allogeneic hematopoietic SCT. Bone Marrow Transplant 2013; 48: 537–543. 10.1038/bmt.2012.239

[8]

Askaa B, Fischer-Nielsen A, Vindelov L, Haastrup EK, Sengelov H . Treatment of poor graft function after allogeneic hematopoietic cell transplantation with a booster of CD34-selected cells infused without conditioning. Bone Marrow Transplant 2014; 49: 720–721. 10.1038/bmt.2014.5

[9]

Klyuchnikov E, El-Cheikh J, Sputtek A, Lioznov M, Calmels B, Furst S et al. CD34(+)-selected stem cell boost without further conditioning for poor graft function after allogeneic stem cell transplantation in patients with hematological malignancies. Biol Blood Marrow Transplant 2014; 20: 382–386. 10.1016/j.bbmt.2013.11.034

[10]

Stasia A, Ghiso A, Galaverna F, RaiolaAM, Gualandi F, Luchetti S et al. CD34 selected cells for the treatment of poor graft function after allogeneic stem cell transplantation. Biol Blood Marrow Transplant 2014; 20: 1440–1443. 10.1016/j.bbmt.2014.05.016

[11]

Scadden DT . The stem-cell niche as an entity of action. Nature 2006; 441: 1075–1079. 10.1038/nature04957

[12]

Calvi LM, Adams GB, Weibrecht KW, Weber JM, Olson DP, Knight MC et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003; 425: 841–846. 10.1038/nature02040

[13]

Hooper AT, Butler JM, Nolan DJ, Kranz A, Iida K, Kobayashi M et al. Engraftment and reconstitution of hematopoiesis is dependent on VEGFR2-mediated regeneration of sinusoidal endothelial cells. Cell Stem Cell 2009; 4: 263–274. 10.1016/j.stem.2009.01.006

[14]

Ding L, Saunders TL, Enikolopov G, Morrison SJ . Endothelial and perivascular cells maintain haematopoietic stem cells. Nature 2012; 481: 457–462. 10.1038/nature10783

[15]

Kong Y, Hu Y, Zhang XH, Wang YZ, Mo XD, Zhang YY et al. Association between an impaired bone marrow vascular microenvironment and prolonged isolated thrombocytopenia after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2014; 20: 1190–1197. 10.1016/j.bbmt.2014.04.015

[16]

Wacholder S, Silverman DT, McLaughlin JK, Mandel JS . Selection of controls in case-control studies. III. Design options. Am J Epidemiol 1992; 135: 1042–1050. 10.1093/oxfordjournals.aje.a116398

[17]

Wang Y, Wu DP, Liu QF, Qin YZ, Wang JB, Xu LP et al. In adults with t(8;21)AML, posttransplant RUNX1/RUNX1T1-based MRD monitoring, rather than c-KIT mutations,allows further risk stratification. Blood 2014; 124: 1880–1886. 10.1182/blood-2014-03-563403

[18]

Huang XJ, Zhu HH, Chang YJ, Xu LP, Liu DH, Zhang XH et al. The superiority of haploidentical related stem cell transplantation over chemotherapy alone as postremission treatment for patients with intermediate- or high-risk acute myeloid leukemia in first complete remission. Blood 2012; 119: 5584–5590. 10.1182/blood-2011-11-389809

[19]

Yan CH, Liu DH, Liu KY, Xu LP, Liu YR, Chen H et al. Risk stratification-directed donor lymphocyte infusion could reduce relapse of standard-risk acute leukemia patients after allogeneic hematopoietic stem cell transplantation. Blood 2012; 119: 3256–3262. 10.1182/blood-2011-09-380386

[20]

Xu LP, Huang XJ, Guo NL, Ren HY, Zhang YC, Lu DP . [Detection of cytomegalovirus infection by polymerase chain reaction in hematopoietic stem cell transplantation recipients]. Zhonghua Xue Ye Xue Za Zhi 2003; 24: 407–409.

[21]

Dominietto A, Raiola AM, van Lint MT, Lamparelli T, Gualandi F, Berisso G et al. Factors influencing haematological recovery after allogeneic haemopoietic stem cell transplants: graft-versus-host disease, donor type, cytomegalovirus infections and cell dose. Br J Haematol 2001; 112: 219–227. 10.1046/j.1365-2141.2001.02468.x

[22]

Shono Y, Ueha S, Wang Y, Abe J, Kurachi M, Matsuno Y et al. Bone marrow graft versus-host disease: early destruction of hematopoietic niche after MHC mismatched hematopoietic stem cell transplantation. Blood 2010; 115: 5401–5411. 10.1182/blood-2009-11-253559

[23]

Yao Y, Song X, Cheng H, Tang G, Hu X, Zhou H et al. Dysfunction of bone marrow vascular niche in acute graft-versus-host disease after MHC-haploidentical bone marrow transplantation. PLoS ONE 2014; 9: e104607. 10.1371/journal.pone.0104607

[24]

Simmons P, Kaushansky K, Torok-Storb B . Mechanisms of cytomegalovirus-mediated myelosuppression: perturbation of stromal cell function versus direct infection of myeloid cells. Proc Natl Acad Sci USA 1990; 87: 1386–1390. 10.1073/pnas.87.4.1386

[25]

Mesenchymal and haematopoietic stem cells form a unique bone marrow niche

Simón Méndez-Ferrer, Tatyana V. Michurina, Francesca Ferraro et al.

Nature 2010 10.1038/nature09262

[26]

Ball LM, Bernardo ME, Roelofs H, Lankester A, Cometa A, Egeler RM et al. Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation. Blood 2007; 110: 2764–2767. 10.1182/blood-2007-04-087056

Cited By

47

Poor graft function after allogeneic hematopoietic stem cell transplantation is associated with a severely altered bone marrow endothelial microenvironment, as revealed by CD31 expression: An Egyptian single center experience

Mary Gamal Naguib, Nermin Adel Nabih Abdel-Ghafar · 2026

Transplant Immunology

Validation of Housekeeping Genes as Reference for Reverse-Transcription-qPCR Analysis in Busulfan-Injured Microvascular Endothelial Cells

Wen Ju, Alhaji Osman Smith · 2018

BioMed Research International

Metrics

47

Citations

26

References

Details

Published: Oct 05, 2015
Vol/Issue: 51(2)
Pages: 249-255
License: View

Authors

Cite This Article

Y Kong, Y-T Wang, W Han, et al. (2015). The bone marrow microenvironment is similarly impaired in allogeneic hematopoietic stem cell transplantation patients with early and late poor graft function. Bone Marrow Transplantation, 51(2), 249-255. https://doi.org/10.1038/bmt.2015.229

The bone marrow microenvironment is similarly impaired in allogeneic hematopoietic stem cell transplantation patients with early and late poor graft function

You May Also Like